ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transthyretin Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-3L9695
Home | Market Reports | Health| Pharmacy
Global Transthyretin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Transthyretin Market Research Report 2025

Code: QYRE-Auto-3L9695
Report
September 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alnylam Pharmaceuticals Inc
Arcturus Therapeutics Inc
Ionis Pharmaceuticals Inc
Neurimmune Holding AG
Pfizer Inc
Prothena Corp Plc
Regeneron Pharmaceuticals Inc

Transthyretin Market

The global market for Transthyretin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Transthyretin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Transthyretin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Transthyretin include Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc, Neurimmune Holding AG, Pfizer Inc, Prothena Corp Plc, Regeneron Pharmaceuticals Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transthyretin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transthyretin.
The Transthyretin market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transthyretin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transthyretin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Transthyretin Market Report

Report Metric Details
Report Name Transthyretin Market
Segment by Type
  • AG-10
  • ALN-TTRsc02
  • CRX-1008
  • EDE-1307
  • Inotersen Sodium
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc, Neurimmune Holding AG, Pfizer Inc, Prothena Corp Plc, Regeneron Pharmaceuticals Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Transthyretin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Transthyretin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Transthyretin Market report?

Ans: The main players in the Transthyretin Market are Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc, Neurimmune Holding AG, Pfizer Inc, Prothena Corp Plc, Regeneron Pharmaceuticals Inc

What are the Application segmentation covered in the Transthyretin Market report?

Ans: The Applications covered in the Transthyretin Market report are Familial Amyloid Neuropathies, Alzheimer's Disease, Cardomyopathy, Neuropathy, Others

What are the Type segmentation covered in the Transthyretin Market report?

Ans: The Types covered in the Transthyretin Market report are AG-10, ALN-TTRsc02, CRX-1008, EDE-1307, Inotersen Sodium, Others

Recommended Reports

Heart Disease Treatments

Neurological Disorders

Ophthalmic and Diagnostic

1 Transthyretin Market Overview
1.1 Product Definition
1.2 Transthyretin by Type
1.2.1 Global Transthyretin Market Value Comparison by Type (2024 VS 2031)
1.2.2 AG-10
1.2.3 ALN-TTRsc02
1.2.4 CRX-1008
1.2.5 EDE-1307
1.2.6 Inotersen Sodium
1.2.7 Others
1.3 Transthyretin by Application
1.3.1 Global Transthyretin Market Value by Application (2024 VS 2031)
1.3.2 Familial Amyloid Neuropathies
1.3.3 Alzheimer's Disease
1.3.4 Cardomyopathy
1.3.5 Neuropathy
1.3.6 Others
1.4 Global Transthyretin Market Size Estimates and Forecasts
1.4.1 Global Transthyretin Revenue 2020-2031
1.4.2 Global Transthyretin Sales 2020-2031
1.4.3 Global Transthyretin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Transthyretin Market Competition by Manufacturers
2.1 Global Transthyretin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Transthyretin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Transthyretin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Transthyretin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transthyretin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transthyretin, Product Type & Application
2.7 Global Key Manufacturers of Transthyretin, Date of Enter into This Industry
2.8 Global Transthyretin Market Competitive Situation and Trends
2.8.1 Global Transthyretin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Transthyretin Players Market Share by Revenue
2.8.3 Global Transthyretin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transthyretin Market Scenario by Region
3.1 Global Transthyretin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Transthyretin Sales by Region: 2020-2031
3.2.1 Global Transthyretin Sales by Region: 2020-2025
3.2.2 Global Transthyretin Sales by Region: 2026-2031
3.3 Global Transthyretin Revenue by Region: 2020-2031
3.3.1 Global Transthyretin Revenue by Region: 2020-2025
3.3.2 Global Transthyretin Revenue by Region: 2026-2031
3.4 North America Transthyretin Market Facts & Figures by Country
3.4.1 North America Transthyretin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Transthyretin Sales by Country (2020-2031)
3.4.3 North America Transthyretin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transthyretin Market Facts & Figures by Country
3.5.1 Europe Transthyretin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Transthyretin Sales by Country (2020-2031)
3.5.3 Europe Transthyretin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transthyretin Market Facts & Figures by Region
3.6.1 Asia Pacific Transthyretin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Transthyretin Sales by Region (2020-2031)
3.6.3 Asia Pacific Transthyretin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Transthyretin Market Facts & Figures by Country
3.7.1 Latin America Transthyretin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Transthyretin Sales by Country (2020-2031)
3.7.3 Latin America Transthyretin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transthyretin Market Facts & Figures by Country
3.8.1 Middle East and Africa Transthyretin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Transthyretin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Transthyretin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transthyretin Sales by Type (2020-2031)
4.1.1 Global Transthyretin Sales by Type (2020-2025)
4.1.2 Global Transthyretin Sales by Type (2026-2031)
4.1.3 Global Transthyretin Sales Market Share by Type (2020-2031)
4.2 Global Transthyretin Revenue by Type (2020-2031)
4.2.1 Global Transthyretin Revenue by Type (2020-2025)
4.2.2 Global Transthyretin Revenue by Type (2026-2031)
4.2.3 Global Transthyretin Revenue Market Share by Type (2020-2031)
4.3 Global Transthyretin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Transthyretin Sales by Application (2020-2031)
5.1.1 Global Transthyretin Sales by Application (2020-2025)
5.1.2 Global Transthyretin Sales by Application (2026-2031)
5.1.3 Global Transthyretin Sales Market Share by Application (2020-2031)
5.2 Global Transthyretin Revenue by Application (2020-2031)
5.2.1 Global Transthyretin Revenue by Application (2020-2025)
5.2.2 Global Transthyretin Revenue by Application (2026-2031)
5.2.3 Global Transthyretin Revenue Market Share by Application (2020-2031)
5.3 Global Transthyretin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Alnylam Pharmaceuticals Inc
6.1.1 Alnylam Pharmaceuticals Inc Company Information
6.1.2 Alnylam Pharmaceuticals Inc Description and Business Overview
6.1.3 Alnylam Pharmaceuticals Inc Transthyretin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Alnylam Pharmaceuticals Inc Transthyretin Product Portfolio
6.1.5 Alnylam Pharmaceuticals Inc Recent Developments/Updates
6.2 Arcturus Therapeutics Inc
6.2.1 Arcturus Therapeutics Inc Company Information
6.2.2 Arcturus Therapeutics Inc Description and Business Overview
6.2.3 Arcturus Therapeutics Inc Transthyretin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Arcturus Therapeutics Inc Transthyretin Product Portfolio
6.2.5 Arcturus Therapeutics Inc Recent Developments/Updates
6.3 Ionis Pharmaceuticals Inc
6.3.1 Ionis Pharmaceuticals Inc Company Information
6.3.2 Ionis Pharmaceuticals Inc Description and Business Overview
6.3.3 Ionis Pharmaceuticals Inc Transthyretin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ionis Pharmaceuticals Inc Transthyretin Product Portfolio
6.3.5 Ionis Pharmaceuticals Inc Recent Developments/Updates
6.4 Neurimmune Holding AG
6.4.1 Neurimmune Holding AG Company Information
6.4.2 Neurimmune Holding AG Description and Business Overview
6.4.3 Neurimmune Holding AG Transthyretin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Neurimmune Holding AG Transthyretin Product Portfolio
6.4.5 Neurimmune Holding AG Recent Developments/Updates
6.5 Pfizer Inc
6.5.1 Pfizer Inc Company Information
6.5.2 Pfizer Inc Description and Business Overview
6.5.3 Pfizer Inc Transthyretin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Inc Transthyretin Product Portfolio
6.5.5 Pfizer Inc Recent Developments/Updates
6.6 Prothena Corp Plc
6.6.1 Prothena Corp Plc Company Information
6.6.2 Prothena Corp Plc Description and Business Overview
6.6.3 Prothena Corp Plc Transthyretin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Prothena Corp Plc Transthyretin Product Portfolio
6.6.5 Prothena Corp Plc Recent Developments/Updates
6.7 Regeneron Pharmaceuticals Inc
6.7.1 Regeneron Pharmaceuticals Inc Company Information
6.7.2 Regeneron Pharmaceuticals Inc Description and Business Overview
6.7.3 Regeneron Pharmaceuticals Inc Transthyretin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Regeneron Pharmaceuticals Inc Transthyretin Product Portfolio
6.7.5 Regeneron Pharmaceuticals Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transthyretin Industry Chain Analysis
7.2 Transthyretin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transthyretin Production Mode & Process Analysis
7.4 Transthyretin Sales and Marketing
7.4.1 Transthyretin Sales Channels
7.4.2 Transthyretin Distributors
7.5 Transthyretin Customer Analysis
8 Transthyretin Market Dynamics
8.1 Transthyretin Industry Trends
8.2 Transthyretin Market Drivers
8.3 Transthyretin Market Challenges
8.4 Transthyretin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Alnylam Pharmaceuticals Inc
Arcturus Therapeutics Inc
Ionis Pharmaceuticals Inc
Neurimmune Holding AG
Pfizer Inc
Prothena Corp Plc
Regeneron Pharmaceuticals Inc
List of Tables
 Table 1. Global Transthyretin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Transthyretin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Transthyretin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Transthyretin Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Transthyretin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Transthyretin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Transthyretin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Transthyretin Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Transthyretin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Transthyretin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Transthyretin, Product Type & Application
 Table 12. Global Key Manufacturers of Transthyretin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Transthyretin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Transthyretin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Transthyretin Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Transthyretin Sales Market Share by Region (2020-2025)
 Table 19. Global Transthyretin Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Transthyretin Sales Market Share by Region (2026-2031)
 Table 21. Global Transthyretin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Transthyretin Revenue Market Share by Region (2020-2025)
 Table 23. Global Transthyretin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Transthyretin Revenue Market Share by Region (2026-2031)
 Table 25. North America Transthyretin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Transthyretin Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Transthyretin Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Transthyretin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Transthyretin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Transthyretin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Transthyretin Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Transthyretin Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Transthyretin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Transthyretin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Transthyretin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Transthyretin Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Transthyretin Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Transthyretin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Transthyretin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Transthyretin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Transthyretin Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Transthyretin Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Transthyretin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Transthyretin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Transthyretin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Transthyretin Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Transthyretin Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Transthyretin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Transthyretin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Transthyretin Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Transthyretin Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Transthyretin Sales Market Share by Type (2020-2025)
 Table 53. Global Transthyretin Sales Market Share by Type (2026-2031)
 Table 54. Global Transthyretin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Transthyretin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Transthyretin Revenue Market Share by Type (2020-2025)
 Table 57. Global Transthyretin Revenue Market Share by Type (2026-2031)
 Table 58. Global Transthyretin Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Transthyretin Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Transthyretin Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Transthyretin Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Transthyretin Sales Market Share by Application (2020-2025)
 Table 63. Global Transthyretin Sales Market Share by Application (2026-2031)
 Table 64. Global Transthyretin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Transthyretin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Transthyretin Revenue Market Share by Application (2020-2025)
 Table 67. Global Transthyretin Revenue Market Share by Application (2026-2031)
 Table 68. Global Transthyretin Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Transthyretin Price (USD/Pcs) by Application (2026-2031)
 Table 70. Alnylam Pharmaceuticals Inc Company Information
 Table 71. Alnylam Pharmaceuticals Inc Description and Business Overview
 Table 72. Alnylam Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Alnylam Pharmaceuticals Inc Transthyretin Product
 Table 74. Alnylam Pharmaceuticals Inc Recent Developments/Updates
 Table 75. Arcturus Therapeutics Inc Company Information
 Table 76. Arcturus Therapeutics Inc Description and Business Overview
 Table 77. Arcturus Therapeutics Inc Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Arcturus Therapeutics Inc Transthyretin Product
 Table 79. Arcturus Therapeutics Inc Recent Developments/Updates
 Table 80. Ionis Pharmaceuticals Inc Company Information
 Table 81. Ionis Pharmaceuticals Inc Description and Business Overview
 Table 82. Ionis Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Ionis Pharmaceuticals Inc Transthyretin Product
 Table 84. Ionis Pharmaceuticals Inc Recent Developments/Updates
 Table 85. Neurimmune Holding AG Company Information
 Table 86. Neurimmune Holding AG Description and Business Overview
 Table 87. Neurimmune Holding AG Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Neurimmune Holding AG Transthyretin Product
 Table 89. Neurimmune Holding AG Recent Developments/Updates
 Table 90. Pfizer Inc Company Information
 Table 91. Pfizer Inc Description and Business Overview
 Table 92. Pfizer Inc Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Pfizer Inc Transthyretin Product
 Table 94. Pfizer Inc Recent Developments/Updates
 Table 95. Prothena Corp Plc Company Information
 Table 96. Prothena Corp Plc Description and Business Overview
 Table 97. Prothena Corp Plc Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Prothena Corp Plc Transthyretin Product
 Table 99. Prothena Corp Plc Recent Developments/Updates
 Table 100. Regeneron Pharmaceuticals Inc Company Information
 Table 101. Regeneron Pharmaceuticals Inc Description and Business Overview
 Table 102. Regeneron Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Regeneron Pharmaceuticals Inc Transthyretin Product
 Table 104. Regeneron Pharmaceuticals Inc Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Transthyretin Distributors List
 Table 108. Transthyretin Customers List
 Table 109. Transthyretin Market Trends
 Table 110. Transthyretin Market Drivers
 Table 111. Transthyretin Market Challenges
 Table 112. Transthyretin Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Transthyretin
 Figure 2. Global Transthyretin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Transthyretin Market Share by Type: 2024 & 2031
 Figure 4. AG-10 Product Picture
 Figure 5. ALN-TTRsc02 Product Picture
 Figure 6. CRX-1008 Product Picture
 Figure 7. EDE-1307 Product Picture
 Figure 8. Inotersen Sodium Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Transthyretin Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Transthyretin Market Share by Application: 2024 & 2031
 Figure 12. Familial Amyloid Neuropathies
 Figure 13. Alzheimer's Disease
 Figure 14. Cardomyopathy
 Figure 15. Neuropathy
 Figure 16. Others
 Figure 17. Global Transthyretin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Transthyretin Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Transthyretin Sales (2020-2031) & (K Pcs)
 Figure 20. Global Transthyretin Average Price (USD/Pcs) & (2020-2031)
 Figure 21. Transthyretin Report Years Considered
 Figure 22. Transthyretin Sales Share by Manufacturers in 2024
 Figure 23. Global Transthyretin Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Transthyretin Players: Market Share by Revenue in Transthyretin in 2024
 Figure 25. Transthyretin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Transthyretin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Transthyretin Sales Market Share by Country (2020-2031)
 Figure 28. North America Transthyretin Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Transthyretin Sales Market Share by Country (2020-2031)
 Figure 32. Europe Transthyretin Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Transthyretin Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Transthyretin Revenue Market Share by Region (2020-2031)
 Figure 40. China Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Transthyretin Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Transthyretin Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Transthyretin Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Transthyretin Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. UAE Transthyretin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Transthyretin by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Transthyretin by Type (2020-2031)
 Figure 62. Global Transthyretin Price (USD/Pcs) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Transthyretin by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Transthyretin by Application (2020-2031)
 Figure 65. Global Transthyretin Price (USD/Pcs) by Application (2020-2031)
 Figure 66. Transthyretin Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Transthyretin Amyloidosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Thyroid Hormones Market Research Report 2024
Global Thymine Market Research Report 2025
Transthyretin amyloid cardiomyopathy ATTR CM Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pyridoxine Market Research Report 2024
Global Retinyl Retinoate Market Research Report 2025
Global Men s Multivitamin Market Research Report 2024
Global Topiramate Market Research Report 2024
Global Calcipotriol Market Research Report 2024
Global Thymomodulin Market Research Report 2024
Global Thymosin Market Research Report 2024
Global Nesiritide Market Research Report 2024
Global Retinoids Market Research Report 2025
Global Fibroin Market Research Report 2024
Global All Trans Retinoic Acid Market Research Report 2025
Global Hepcidin Market Research Report 2024
Global Transmembrane Protein Market Research Report 2025
Global Dithioerythritol Market Research Report 2024
Global Liothyronine Market Research Report 2025
Global Tritylamine Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions